NEURAXON INC has a total of 91 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are MIIKANA THERAPEUTICS INC, YM BIOSCIENCES AUSTRALIA PTY and CHARRIER JEAN-DAMIEN.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 8 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | United States | 8 | |
#4 | WIPO (World Intellectual Property Organization) | 8 | |
#5 | Australia | 7 | |
#6 | Argentina | 5 | |
#7 | China | 5 | |
#8 | Mexico | 5 | |
#9 | Taiwan | 5 | |
#10 | Republic of Korea | 4 | |
#11 | New Zealand | 4 | |
#12 | South Africa | 4 | |
#13 | Brazil | 3 | |
#14 | Chile | 3 | |
#15 | Israel | 3 | |
#16 | EAPO (Eurasian Patent Organization) | 2 | |
#17 | Japan | 2 | |
#18 | Singapore | 2 | |
#19 | Ukraine | 2 | |
#20 | Hong Kong | 1 | |
#21 | Malaysia | 1 | |
#22 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Maddaford Shawn | 73 |
#2 | Rakhit Suman | 73 |
#3 | Ramnauth Jailall | 68 |
#4 | Annedi Subhash C | 64 |
#5 | Renton Paul | 52 |
#6 | Patman Joanne | 43 |
#7 | Silverman Sarah | 24 |
#8 | Dove Peter | 24 |
#9 | Andrews John S | 15 |
#10 | Andrews John | 13 |
Publication | Filing date | Title |
---|---|---|
WO2010132072A1 | Treatment or prevention of migraine by dosing at aura | |
WO2010000073A1 | Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity | |
BRPI0820632A2 | Indole Compounds and Methods for Treating Visceral Pain | |
EP2220074A1 | 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity | |
TW200902003A | Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity | |
CN101466709A | 1,5 and 3,6- substituted indole compounds having NOS inhibitory activity | |
CA2607219A1 | Substituted benzimidazole compounds with dual nos inhibitory activity and mu opioid agonist activity | |
CN101247853A | Substituted indole compounds having NOS inhibitory activity | |
EP1539724A1 | Amino benzothiazole compounds with nos inhibitory activity | |
US6919328B1 | Tricyclic compounds with NOS activity |